Quentin Bayard

Quentin Bayard is a Research Scientist at Owkin since September 2021, previously engaged in a PhD project at Inserm from September 2017 to June 2021, focusing on the integration of genomic and transcriptomic data from liver tumors to identify cancer-related alterations. Early research experiences include a Master 2 internship in Genomics and Bioinformatics at Inserm, a project on predicting drugability of protein pockets using machine learning at Molécules Thérapeutiques In silico, and work on transgene expression related to gene therapy at Genethon. Academic qualifications include a PhD in Oncology and Cancer Biology from Université Paris Cité, a Master's in Bioinformatics, an engineering degree in Biotechnology from UTC, and a DUT in Biological Engineering.